NCT03195166

Brief Summary

Compared to single-dose spinal anesthesia, continuous spinal anesthesia using small titrated doses of local anesthetic, was safe, efficient and provided better hemodynamic profile in elderly patients. The aim of this study was to investigate the hemodynamic effects of continuous spinal anesthesia in elderly patients undergoing knee arthroplasty. Investigators use the FloTrac sensor/Vigileo haemodynamic monitoring system to assess modification blood pressure, stroke volume and cardiac output during anesthesia and specialy after every bolus of spinal anesthesia, after inflating the tourniquet and after putting it off. they recorded number of hypotension episodes, ephedrine bolus and consumption until 2 hours after the end of surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 4, 2017

Completed
18 days until next milestone

First Posted

Study publicly available on registry

June 22, 2017

Completed
4 months until next milestone

Study Start

First participant enrolled

November 3, 2017

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2020

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2020

Completed
Last Updated

February 13, 2024

Status Verified

February 1, 2024

Enrollment Period

2.7 years

First QC Date

June 4, 2017

Last Update Submit

February 11, 2024

Conditions

Keywords

elderly spinal anesthesia

Outcome Measures

Primary Outcomes (1)

  • hemodynamic profile during continuous spinal anesthesia in elderly

    cardiac output , L/min

    Day 0

Secondary Outcomes (3)

  • blood pressure variation

    Day 0

  • ephedrine use

    Day 0

  • stoke volume modification

    Day 0

Study Arms (1)

hemodynamic profile

EXPERIMENTAL

FloTrac sensor/Vigileo

Diagnostic Test: FloTrac sensor/Vigileo

Interventions

FloTrac sensor/VigileoDIAGNOSTIC_TEST

blood pressure (systolic, diastolic and mean), stroke volume cardiac output ephedrine consumption after bupivacaine continuous spinal anesthesia

hemodynamic profile

Eligibility Criteria

Age65 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Adult patients, aged more than 65 years
  • scheduled for elective total knee arthroplasty
  • under regional anesthesia

You may not qualify if:

  • contraindication to regional anesthesia
  • or the patients who refused to give consent,
  • patients with anemia (hemoglobin \< 13 g/dl for male and hemoglobin \< 12 g/dl for female),
  • cardiac arrhythmias,
  • NYHA score \> 2,
  • ASA \> 2
  • Cardiac ejection fraction \< 50 %,
  • valvulopathy,
  • pulmonary artery hypertension
  • and relaxation abnormality

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kassab orthopedic Institute

Tunis, La Manouba, 2010, Tunisia

Location

Study Officials

  • KAABACHI OLFA, PROF

    KASSAB ORTHOPEDIC INSTITUTE

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
consecutive patient
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: The aim of this study was to investigate the hemodynamic effects of continuous spinal anesthesia in elderly patients. An oral intake of 250 ml of water was taken 2 hours before surgery. Radial arterial catheter was putted under local anesthesia and connected to the FloTrac sensor/Vigileo haemodynamic monitoring system. Fluid therapy was limited to 4 ml/kg/h until tourniquet release. Subarachnoid puncture was performed at the L3-S1 interspace. An initial dose of 2,5 mg isobaric 0,5% bupivacaine was injected. Additional 2,5 mg isobaric 0,5% bupivacaine doses were injected every 10 minutes until sensory blockade reached T10. Ephedrine 6 to 9 mg was given if systolic arterial pressure \< 90 mmHg. Investigators measured blood pressure (systolic, diastolic and mean), stroke volume and cardiac output every 5 minutes from beginning of the operation and until 2 hours after the end. Number of hypotension episodes and ephedrine consumption were noted.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
professor

Study Record Dates

First Submitted

June 4, 2017

First Posted

June 22, 2017

Study Start

November 3, 2017

Primary Completion

June 30, 2020

Study Completion

December 31, 2020

Last Updated

February 13, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations